JACOBS LEVY EQUITY MANAGEMENT, INC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 74 filers reported holding ANTHERA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 2.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2016$254,000
+2.8%
82,175
+20.3%
0.01%0.0%
Q1 2016$247,000
+268.7%
68,300
+371.0%
0.01%
+400.0%
Q4 2015$67,000
-43.2%
14,500
-24.9%
0.00%
-50.0%
Q3 2015$118,000
-64.0%
19,300
-49.2%
0.00%
-66.7%
Q2 2015$328,000
+81.2%
38,000
-6.2%
0.01%
+100.0%
Q1 2015$181,000
+144.6%
40,500
-13.5%
0.00%
+200.0%
Q4 2014$74,000
-55.2%
46,800
-45.5%
0.00%
-66.7%
Q3 2014$165,000
+251.1%
85,842
+520.2%
0.00%
+200.0%
Q2 2014$47,000
-4.1%
13,842
-5.2%
0.00%0.0%
Q1 2014$49,000
-65.5%
14,600
-58.6%
0.00%
-50.0%
Q3 2013$142,00035,2640.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,250,000$1,975,0001.00%
Broadfin Capital, LLC 3,567,624$5,636,0000.24%
Abingworth LLP 437,994$679,0000.19%
GREAT POINT PARTNERS LLC 250,000$395,0000.19%
Rhenman & Partners Asset Management AB 400,000$632,0000.18%
BVF INC/IL 559,624$884,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$2,673,0000.10%
Perceptive Advisors 503,156$795,0000.07%
Gruss Capital Management LP 960,000$1,517,0000.04%
Spark Investment Management LLC 103,400$160,0000.03%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders